Just What the Doctor Ordered?: A Look at the Side Effects of Theratechnologies on Secondary Market Liability in Canada

By Stéphane Rousseau, Dominique Payette and Christopher Trouvé. Originally published on the Canadian Bar Review. The recent decision of the Supreme Court of Canada in Theratechnologies Inc. v 121851 Canada Inc. (“Thera”) goes to the heart of the debate on the place of the public and private enforcement methods in the Canadian securities regulation regime. Fundamentally, the case concerns …

Continue reading Just What the Doctor Ordered?: A Look at the Side Effects of Theratechnologies on Secondary Market Liability in Canada